Lupin has got the final approval from the US Food and Drug Administration (FDA) for it’s armodafinil tablet (in strengthens of 50 mg, 150 mg, 200 mg, and 250 mg), that is used in treating sleep disorder.

Lupin Pharmaceuticals Inc (LPI), its US subsidiary is expected to commence promotion of this approved product, a generic version of Cephalon Inc’s Nuvigil tablets in the US shortly.

Read EquityPandit’s Technical Analysis on Nifty Pharma